See the latest open-label extension data for Ocrevus

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis, Ocrevus

Examine 2 years of controlled and 3+ years of open-label
extension efficacy and safety data.


 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Click HERE to Register for the MS Beacon Newsletter
…………………………………………………………………


This Article is Provided by:  #MSViewsandNews
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews